HighTower Advisors
MLAB icon

HighTower Advisors’s Mesa Laboratories MLAB Stock Holding History

HighTower Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,405
Closed -$377K – 3333
2021
Q2 		$377K Buy
1,405
+6
+0.4% +$1.52K ﹤0.01% 2218
2021
Q1 		$334K Buy
1,399
+50
+4% +$13.8K ﹤0.01% 2224
2020
Q4 		$390K Buy
1,349
+183
+16% +$50.3K ﹤0.01% 1764
2020
Q3 		$303K Sell
1,166
-79
-6% -$18.8K ﹤0.01% 1825
2020
Q2 		$267K Buy
1,245
+253
+26% +$58.3K ﹤0.01% 1809
2020
Q1 		$223K Buy
992
+153
+18% +$37.7K ﹤0.01% 1731
2019
Q4 		$205K Buy
+839
New +$197K ﹤0.01% 1959

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

HighTower Advisors's MLAB Position: Q3 2021 in Review

HighTower Advisors sold out of Mesa Laboratories (MLAB) in Q3 2021, closing a stake of 1,405 shares — an estimated $377K sold.

HighTower Advisors first reported a position in MLAB in Q4 2019 and held it in 7 quarters. The position peaked at $390K in Q4 2020. 172 funds tracked by Wall St. Rank hold MLAB as of Q3 2021.

  • HighTower Advisors reported no remaining Mesa Laboratories position as of Q3 2021 after selling out during the quarter.
  • HighTower Advisors sold 1,405 Mesa Laboratories shares in Q3 2021, an estimated $377K.
  • HighTower Advisors first reported a position in Mesa Laboratories in Q4 2019 and held it in 7 quarters.
  • HighTower Advisors's Mesa Laboratories position peaked at $390K in Q4 2020.
  • 172 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2021.

Based on HighTower Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.